{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~47 mi. (Kearney, Nebraska, +523 more cities)
facility
CHI Health Good Samaritan
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~47 mi. (Kearney, Nebraska, +454 more cities)
facility
CHI Health Good Samaritan
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~47 mi. (Kearney, Nebraska, +825 more cities)
facility
CHI Health Good Samaritan
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~47 mi. (Kearney, Nebraska, +327 more cities)
facility
CHI Health Good Samaritan
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types